Sep 07, 2022 / 05:00PM GMT
Peter Verdult - Citigroup Inc., Research Division - MD
Okay. So welcome to the fireside chat with Jazz Pharmaceuticals. We've got a number of management team here. I'm delighted, well, I'm Peter Verdult from Citi from health care team based in Europe. I'm delighted to be introducing Renee Gala, who's the CFO at Jazz Pharma.
And we've got some surprise additions today. Kim Sablich who's the President, LGM of North America and Rob Iannone, who is Head of R&D. Now those who are in the room will probably spot I'm not exactly a U.S. spec generic pharma analyst, but I know not to be dangerous given my prior coverage, but I've been asked to step in and moderate this session.
I'm here to moderate, not monopolize. So are there any questions from the room at any point in time, I will be scanning my eyes over the room, and there stick your hand up, and we'll put your questions through to management. So Renee and team, thank you very much for joining us. I think you would like to start with some preprepared remarks before I [taper] you with my questions. So over to you.
Renee D.
Jazz Pharmaceuticals PLC at Citi BioPharma Conference Transcript
Sep 07, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers